Table 3.
Model 11 | Model 21after-group split by referral to a CPP or not | |||||
---|---|---|---|---|---|---|
During vs. before | After vs. before | After-CPP vs. before | After-no CPP vs. before | After-CPP vs. during | After-no CPP vs. during | |
Estimate (95% CI) | Estimate (95% CI) | Estimate (95% CI) | Estimate (95% CI) | Estimate (95% CI) | Estimate (95% CI) | |
Percentile | ||||||
25th | −7 (−8;-5) | −10 (−11;-8) | −12 (−13;-11) | −6 (−8;-5) | −8 (−9;-7) | 0 (−2;1) |
50th | −14 (−16;-11) | −17 (−19;-15) | −23 (−25;-21) | −9 (−12;-7) | −15 (−17;-12) | 4 (1;7) |
75th | −22 (−27;-16) | −27 (−34;-20) | −46 (−51;-41) | −11 (−21;-1) | −32 (−37;-28) | 10 (1;19) |
90th | −53 (−76;-30) | −44 (−65;-23) | −110 (−153;-67) | −6 (−77;66) | −80 (−126;-34) | 48 (−49;145) |
Estimates with 95% confidence intervals (95%CI) are displayed for the 25th, the 50th, the 75th percentile and the 90th percentiles. Bold estimates indicate statistical significance at p = 0.05 level or less.
Model 1 reference: before implementation group, cohort, female, 45 years of age, cancer sites, no co-morbidity, high disposable income and high educational level.
Model 2 = model 1, but with ‘after group’ split by referral route (CPP).
1Adjusted for gender, age, cancer site, co-morbidity, educational level and disposable income.